Irene Giannubilo

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients.

Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients.

Journal: Frontiers in oncology

Published: May 08, 2026

Platinum Rechallenge in Platinum-Resistant Ovarian Cancer: Clinical Outcomes and the Impact of BRCA Status.

Platinum Rechallenge in Platinum-Resistant Ovarian Cancer: Clinical Outcomes and the Impact of BRCA Status.

Journal: Cancers

Published: May 06, 2026

The game changer in the cervical cancer therapeutic landscape: immunotherapy.

The game changer in the cervical cancer therapeutic landscape: immunotherapy.

Journal: Immunotherapy

Published: April 10, 2026

End‑of‑life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center.

End‑of‑life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center.

Journal: BMC cancer

Published: December 18, 2025

Editorial: The essential role of multidisciplinary teams in breast cancer surgery: collaboration for superior patient outcomes.

Editorial: The essential role of multidisciplinary teams in breast cancer surgery: collaboration for superior patient outcomes.

Journal: Frontiers in oncology

Published: November 26, 2025

Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies.

Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 01, 2025

Prognostic disclosure in metastatic breast cancer: a scoping review.

Prognostic disclosure in metastatic breast cancer: a scoping review.

Journal: The oncologist

Published: May 26, 2025

Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis.

Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis.

Journal: European journal of clinical investigation

Published: December 05, 2024

Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria.

Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria.

Journal: Tumori

Published: October 15, 2024

Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world.

Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world.

Journal: ESMO open

Published: August 30, 2024

Controversies on chemotherapy for early HR+/HER2- breast cancer: the role of anthracyclines and dose intensification.

Controversies on chemotherapy for early HR+/HER2- breast cancer: the role of anthracyclines and dose intensification.

Journal: Current opinion in oncology

Published: July 16, 2024

Prognostic implications of risk definitions from the monarchE and NATALEE trials.

Prognostic implications of risk definitions from the monarchE and NATALEE trials.

Journal: Journal of the National Cancer Institute

Published: July 12, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026